Polymorphisms in TSHR and IL1RN genes and the risk and prognosis of Hashimoto’s thyroiditis

References

• Weetman, A. P. 1996. Chronic autoimmune thyroiditis. In Werner and Ingbar’s the Thyroid. L. E. Braverman and R. D. Utiger, eds. Lippincott-Raven, Philadelphia. p. 738–748
   Google Scholar
• Davies, T. F. 1996. The pathogenesis of Grave’s disease. In The Thyroid: A Fundamental Textbook, 7th ed. L. E. Braverman and R. D. Utiger, eds. Lippincott-Press, Philadelphia. p. 525–536
   Google Scholar
• Ban, Y., and Y. Tomer. 2003. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity. 36: 367–379
   PubMed Web of Science ®Google Scholar
• Tomer, Y., G. Barbesino, M. Keddache, et al. 1997. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J. Clin. Endocrinol. Metab. 82: 1645–1648
   PubMed Web of Science ®Google Scholar
• Davies, T. F., T. Ando, R. Y. Lin, et al. 2005. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J. Clin. Invest. 115: 1972–1983
   PubMed Web of Science ®Google Scholar
• Tonacchera, M., and A. Pinchera. 2000. Thyrotropin receptor polymorphisms and thyroid diseases. J. Clin. Endocrinol. Metab. 85: 2637–2639
   PubMed Web of Science ®Google Scholar
• Gabriel, E. M., E. R. Bergert, C. S. Grant, et al. 1999. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J. Clin. Endocrinol. Metab. 84: 3328–3335
   PubMed Web of Science ®Google Scholar
• Muhlberg, T., K. Herrmann, W. Joba, et al. 2000. Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of human thyrotropin receptor in a European Caucasian population. J. Clin. Endocrinol. Metab. 85: 2640–2643
   PubMed Web of Science ®Google Scholar
• Ban, Y., D. A. Greenberg, E. S. Concepcion, and Y. Tomer. 2002. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves’ disease. Thyroid. 12: 1079–1183
   PubMed Web of Science ®Google Scholar
• Ajjan, R. A., C. Findlay, R. A. Metcalfe, et al. 1998. The modulation of the human sodium iodide symporter activity by Graves' disease sera. J. Clin. Endocrinol. Metab. 83: 1217–1221
   PubMed Web of Science ®Google Scholar
• Dinarello, C. A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8: 253–265
   PubMed Web of Science ®Google Scholar
• Tarlow, J. K., A. I. Blakemore, A. Lennard, et al. 1993. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91: 403–404
   PubMed Web of Science ®Google Scholar
• Vamvakopoulos, J., C. Green, and S. Metcalfe. 2002. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 32: 2988–2996
   PubMed Web of Science ®Google Scholar
• Vamvakopoulos, J., C. Taylor, G. J. Morris-Stiff, et al. 2002. The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Euro. J. Immunogenet. 29: 337–340
   PubMedGoogle Scholar
• Steinkasserer, A., K. Koelble, and R. B. Sim. 1991. Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN). Nucl. Acids Res. 19: 5095
   PubMed Web of Science ®Google Scholar
• Danis, V. A., M. Millington, V. J. Hyland, and D. Grennan. 1995. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99: 303–310
   PubMed Web of Science ®Google Scholar
• Hurme, M., and S. Santtila. 1998. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur. J. Immunol. 28: 2598–2602
   PubMed Web of Science ®Google Scholar
• Blakemore, A. I. F., P. F. Watson, A. P. Weetnan, and G. W. Duff. 1995. Association of Graves’ disease with an allele of interleukin 1 receptor antagonist gene. J. Clin. Endocrinol. Metab. 80: 111–115
   PubMed Web of Science ®Google Scholar
• Fang, X. M., S. Schroder, A. Hoeft, and F. Stüber. 1999. Comparison of two polymorphisms of the interleukin 1 gene family: interleukin 1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit. Care. Med. 27: 1330–1334
   PubMed Web of Science ®Google Scholar
• Olerup, O., and H. Zetterquist. 1992. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39: 225–235
   PubMed Web of Science ®Google Scholar
• Settin, A., H. Abdel-Hady, R. El-Baz, and I. Saber. 2007. Gene polymorphisms of TNF-α (-308), IL-10(-1082), IL-6(-174), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr. Cardiol. 28: 363–371
   PubMed Web of Science ®Google Scholar
• Yin, X., R. Latif, R. Bahn, et al. 2008. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Thyroid. 18: 1201–1206
   PubMed Web of Science ®Google Scholar
• Matakidou, A., N. Hamel, S. Popat, et al. 2004. Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. Carcinogenesis. 25: 369–373
   PubMedGoogle Scholar
• Inoue, N., M. Watanabe, Y. Katsumata, et al. 2013. Different genotypes of a functional polymorphism of the TSHR gene are associated with the development and severity of Graves' and Hashimoto's diseases. Tissue Antigens. 82: 288--290
   Google Scholar
• Liu, L., H. Q. Wu, Q. Wang, et al. 2012. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Endocr. J. 59: 717–723
   PubMed Web of Science ®Google Scholar
• Yan, L., Y. L. Yu, J. Yang, et al. 2012. Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity. 45: 533–539
   PubMed Web of Science ®Google Scholar
• Inoue, N., M. Watanabe, M. Wada, et al. 2013. IL-10 -592A/C polymorphism is associated with severity of Hashimoto's disease. Cytokine. 64: 370–374
   PubMed Web of Science ®Google Scholar
• Inoue, N., M. Watanabe, M. Morita, et al. 2011. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin. Exp. Immunol. 163: 318–323
   PubMed Web of Science ®Google Scholar
• Kammoun-Krichen, M., N. Bougacha-Elleuch, K. Makni, et al. 2007. Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur. Cytokine Netw. 18: 196–200
   PubMed Web of Science ®Google Scholar
• Peeters, R. P., H. Van Toor, W. Klootwijk, et al. 2003. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J. Clin. Endocrinol. Metab. 88: 2880–2888
   PubMed Web of Science ®Google Scholar
• Liu, R. D., R. X. Chen, W. R. Li, et al. 2012. The Glu727 allele of thyroid stimulating hormone receptor gene is associated with osteoporosis. N. Am. J. Med. Sci. 4: 300–304
   PubMedGoogle Scholar
• van der Deure, W. M., A. G. Uitterlinden, A. Hofman, et al. 2008. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin. Endocrinol. 68: 175–181
   PubMedGoogle Scholar
• Tomer, Y., and T. F. Davies. 2003. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24: 694–717
   PubMed Web of Science ®Google Scholar
• Luotola, K., P. Mantula, J. Salmi, et al. 2001. Allele 2 of interleukin-1 receptor antagonist gene increases the risk of thyroid peroxidase antibodies in subacute thyroiditis. APMIS 109: 454–460
   PubMedGoogle Scholar
• Blakemore, A. I. F., J. K. Tarlow, M. J. Cork, et al. 1994. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37: 1380–1385
   PubMed Web of Science ®Google Scholar
• Bioque, G., G. Bouma, J. B. A. Crusius, et al. 1996. Evidence for genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105–110
   PubMedGoogle Scholar
• Tarlow, J. K., M. J. Cork, F. E. Clay, et al. 1997. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br. J. Dermatol. 136: 147–148
   PubMedGoogle Scholar